Literature DB >> 15149523

Observations on angiopoietin 2 in patients with angiosarcoma.

Y Amo, M Masuzawa, Y Hamada, K Katsuoka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15149523     DOI： 10.1111/j.1365-2133.2004.05932.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  5 in total

1.  [Medical emergencies following dermatological injections and infusions].

Authors:  D Dill-Müller
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

2.  Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcoma.

Authors:  Sandra P D' Angelo; Michelle R Mahoney; Brian A Van Tine; Douglas R Adkins; Maria T Grosse Perdekamp; Mercedes M Condy; Jason J Luke; Eliza Woodward Hartley; Cristina R Antonescu; William D Tap; Gary K Schwartz
Journal:  Cancer Chemother Pharmacol       Date:  2015-02-12       Impact factor: 3.333

3.  Soluble angiopoietin-2/sTie2 receptor ratio is an independent prognostic marker in adult acute myeloid leukemia.

Authors:  Salah Aref; Nadia El Menshawy; Emaad Azmy; Mohamed El-Refaie
Journal:  Indian J Hematol Blood Transfus       Date:  2009-04-06       Impact factor: 0.900

4.  Endothelial cell malignancies: new insights from the laboratory and clinic.

Authors:  Michael J Wagner; Vinod Ravi; David G Menter; Anil K Sood
Journal:  NPJ Precis Oncol       Date:  2017-04-20

5.  Expression of angiopoietin-TIE system components in angiosarcoma.

Authors:  Darya Buehler; Patrick Rush; Jason R Hasenstein; Stephanie R Rice; Gholam Reza Hafez; B Jack Longley; Kevin R Kozak
Journal:  Mod Pathol       Date:  2013-04-05       Impact factor: 7.842
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.